688136 科兴制药
已收盘 07-30 15:00:00
资讯
新帖
简况
科兴制药:实际控制人兼董事长、董事及高管累计增持约98万股,增持计划实施完毕
每日经济新闻 · 07-30 18:23
科兴制药:实际控制人兼董事长、董事及高管累计增持约98万股,增持计划实施完毕
科兴制药(688136.SH)实控人及部分高管合计增持公司0.49%股份
智通财经网 · 07-30 18:18
科兴制药(688136.SH)实控人及部分高管合计增持公司0.49%股份
科兴制药(688136.SH):相关管理层累计增持1308.85万元公司股份
格隆汇资讯 · 07-30 18:01
科兴制药(688136.SH):相关管理层累计增持1308.85万元公司股份
科兴制药最新公告:注射用紫杉醇获欧盟委员会上市批准
证券之星 · 07-28 16:01
科兴制药最新公告:注射用紫杉醇获欧盟委员会上市批准
科兴制药(688136.SH):注射用紫杉醇(白蛋白结合型)获欧盟委员会上市批准
智通财经 · 07-28 15:37
科兴制药(688136.SH):注射用紫杉醇(白蛋白结合型)获欧盟委员会上市批准
科兴制药(688136)7月22日主力资金净买入51.97万元
证券之星 · 07-23
科兴制药(688136)7月22日主力资金净买入51.97万元
科兴制药:白蛋白紫杉醇预计8月上旬获得上市许可
E公司 · 07-16
科兴制药:白蛋白紫杉醇预计8月上旬获得上市许可
科兴制药07月12日主力资金流出24万元 连续3日减仓
自选股智能写手 · 07-12
科兴制药07月12日主力资金流出24万元 连续3日减仓
生物制品行业盘中跳水,科兴制药跌2.03%
自选股智能写手 · 07-08
生物制品行业盘中跳水,科兴制药跌2.03%
科兴制药大跌5.06% 融资融券余额实现2连增
智选洞察 · 07-04
科兴制药大跌5.06% 融资融券余额实现2连增
6月26日科兴制药涨5.05%,国新国证新锐灵活配置混合基金重仓该股
证券之星 · 06-26
6月26日科兴制药涨5.05%,国新国证新锐灵活配置混合基金重仓该股
科兴制药涨5.05%,天风证券四周前给出“买入”评级
证券之星 · 06-26
科兴制药涨5.05%,天风证券四周前给出“买入”评级
科兴制药大幅上涨 获5家券商给予增持建议
智选洞察 · 06-26
科兴制药大幅上涨 获5家券商给予增持建议
6月24日科兴制药跌5.99%,国新国证新锐灵活配置混合基金重仓该股
证券之星 · 06-24
6月24日科兴制药跌5.99%,国新国证新锐灵活配置混合基金重仓该股
科兴制药下跌5.1%,报16.95元/股
金融界 · 06-24
科兴制药下跌5.1%,报16.95元/股
科兴制药大跌5.10% 近半年5家券商增持
智选洞察 · 06-24
科兴制药大跌5.10% 近半年5家券商增持
A股避雷针:科兴制药近日补缴超2000万税款及滞纳金,东方集团大股东部分股份被强制平仓打开手机微信扫一扫
金融界 · 06-24
A股避雷针:科兴制药近日补缴超2000万税款及滞纳金,东方集团大股东部分股份被强制平仓打开手机微信扫一扫
科兴制药2024国际医药高端论坛成功举办并签署系列战略合作协议
中国财富通 · 06-23
科兴制药2024国际医药高端论坛成功举办并签署系列战略合作协议
科兴制药(688136.SH):补缴税款及滞纳金合计2131.11万元
智通财经 · 06-21
科兴制药(688136.SH):补缴税款及滞纳金合计2131.11万元
科兴制药:于近日补缴税款及滞纳金 合计2131.11万元
第一财经 · 06-21
科兴制药:于近日补缴税款及滞纳金 合计2131.11万元
公司概况
公司名称:
科兴生物制药股份有限公司
所属行业:
医药制造业
上市日期:
2020-12-14
主营业务:
科兴生物制药股份有限公司是一家主要从事重组蛋白药物和微生态制剂的研发、生产、销售一体化的创新型生物制药企业,专注于抗病毒、血液、肿瘤与免疫、退行性疾病等治疗领域的药物研发,并围绕上述治疗领域拥有一定中药及化学药技术沉淀。目前公司主要产品包括重组蛋白药物“重组人促红素”、“重组人干扰素α1b”、“重组人粒细胞刺激因子”,微生态制剂药物“酪酸梭菌二联活菌”。公司是中国重组蛋白药物的领军企业,建立了完善的生物药研发创新体系,涵盖了原核细胞技术、真核细胞技术、微生态活菌技术三大生物技术基础体系。
发行价格:
22.33
{"stockData":{"symbol":"688136","market":"SH","secType":"STK","nameCN":"科兴制药","latestPrice":15.22,"timestamp":1722322800000,"preClose":15.37,"halted":0,"volume":658913,"delay":0,"floatShares":199000000,"shares":199000000,"eps":-0.8491,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.15,"latestTime":"07-30 15:00:00","open":15.23,"high":15.43,"low":15.02,"amount":10035100,"amplitude":0.0267,"askPrice":15.38,"askSize":4,"bidPrice":15.22,"bidSize":16,"shortable":0,"etf":0,"ttmEps":-0.8491,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1722389400000},"adr":0,"adjPreClose":15.37,"symbolType":"stock_kcb","openAndCloseTimeList":[[1722303000000,1722310200000],[1722315600000,1722322800000]],"highLimit":16.91,"lowLimit":13.83,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":199198650,"pbRate":1.87,"roa":"--","roe":"0.76%","epsLYR":-0.96,"committee":-0.144509,"marketValue":3032000000,"floatMarketCap":3032000000,"peRate":-17.924862,"changeRate":-0.0098,"turnoverRate":0.0033,"status":1,"afterMarket":{"amount":0,"volume":0,"close":15.22,"buyVolume":0,"sellVolume":0,"time":1722324837154,"indexStatus":"已收盘 07-30 15:30:00","preClose":15.37}},"requestUrl":"/m/hq/s/688136/wiki","defaultTab":"wiki","newsList":[{"id":"2455198100","title":"科兴制药:实际控制人兼董事长、董事及高管累计增持约98万股,增持计划实施完毕","url":"https://stock-news.laohu8.com/highlight/detail?id=2455198100","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2455198100?lang=zh_cn&edition=full","pubTime":"2024-07-30 18:23","pubTimestamp":1722334984,"startTime":"0","endTime":"0","summary":"本次增持主体的姓名:公司实际控制人兼董事长邓学勤先生,董事、总经理赵彦轻先生,董事、董事会秘书兼财务总监王小琴女士,董事、副总经理崔宁女士以及副总经理邵珂先生、马鸿杰女士。截至2024年7月30日,增持主体通过上海证券交易所交易系统以集中竞价方式累计增持公司股份约98万股,占公司总股本的0.49%,合计增持金额为人民币1308.85万元,已超过相关增持计划下限金额,相关增持计划届满且已实施完毕。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730182338956c6a94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730182338956c6a94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688136"],"gpt_icon":0},{"id":"2455898199","title":"科兴制药(688136.SH)实控人及部分高管合计增持公司0.49%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2455898199","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2455898199?lang=zh_cn&edition=full","pubTime":"2024-07-30 18:18","pubTimestamp":1722334695,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科兴制药(688136.SH)发布公告,截至2024年7月30日,公司实际控制人兼董事长、董事及高级管理人员通过上海证券交易所交易系统以集中竞价方式累计增持公司股份98.01万股,占公司总股本的0.49%,合计增持金额为1308.85万元,已超过本次增持计划下限金额,本次增持计划届满且已实施完毕。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1157507.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["688136","BK0239"],"gpt_icon":0},{"id":"2455866829","title":"科兴制药(688136.SH):相关管理层累计增持1308.85万元公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2455866829","media":"格隆汇资讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2455866829?lang=zh_cn&edition=full","pubTime":"2024-07-30 18:01","pubTimestamp":1722333673,"startTime":"0","endTime":"0","summary":"格隆汇7月30日丨科兴制药(688136.SH)公布,截至2024年7月30日,增持主体通过上海证券交易所交易系统以集中竞价方式累计增持公司股份980,119股,占公司总股本的0.49%,合计增持金额为人民币1,308.85万元,已超过本次增持计划下限金额,本次增持计划届满且已实施完毕。增持主体:公司实际控制人兼董事长邓学勤先生,董事、总经理赵彦轻先生,董事、董事会秘书兼财务总监王小琴女士,董事、副总经理崔宁女士以及副总经理邵珂先生、马鸿杰女士。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730180118956c535c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240730180118956c535c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688136"],"gpt_icon":0},{"id":"2454543659","title":"科兴制药最新公告:注射用紫杉醇获欧盟委员会上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2454543659","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454543659?lang=zh_cn&edition=full","pubTime":"2024-07-28 16:01","pubTimestamp":1722153701,"startTime":"0","endTime":"0","summary":"科兴制药公告,公司合作伙伴浙江海昶生物医药技术有限公司近日收到欧盟委员会通知,公司引进产品注射用紫杉醇(白蛋白结合型)获得欧盟委员会上市批准。该药品适应症为治疗转移性乳腺癌、转移性胰腺癌以及非小细胞肺癌等多种癌症。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072800001273.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688136","BK0239"],"gpt_icon":0},{"id":"2454548599","title":"科兴制药(688136.SH):注射用紫杉醇(白蛋白结合型)获欧盟委员会上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2454548599","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2454548599?lang=zh_cn&edition=full","pubTime":"2024-07-28 15:37","pubTimestamp":1722152245,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科兴制药 发布公告,公司合作伙伴浙江海昶生物医药技术有限公司于近日收到欧盟委员会通知,公司引进产品注射用紫杉醇获得欧盟委员会上市批准。过去五年,欧洲癌症发病率呈上升趋势,白蛋白紫杉醇销量在欧洲市场逐步增长。本次白蛋白紫杉醇获得欧盟委员会上市批准,有利于公司进一步加快推进海外市场的拓展,提高公司的市场竞争力,未来将对公司经营产生积极影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1156505.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688136","BK0239"],"gpt_icon":0},{"id":"2453251827","title":"科兴制药(688136)7月22日主力资金净买入51.97万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453251827","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453251827?lang=zh_cn&edition=full","pubTime":"2024-07-23 08:54","pubTimestamp":1721696098,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月22日收盘,科兴制药报收于16.08元,上涨2.49%,换手率0.46%,成交量9138.0手,成交额1470.8万元。近5日资金流向一览见下表:科兴制药融资融券信息显示,融资方面,当日融资买入92.28万元,融资偿还70.73万元,融资净买入21.55万元,连续3日净买入累计52.9万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072300010594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688136","BK0239"],"gpt_icon":0},{"id":"2451695989","title":"科兴制药:白蛋白紫杉醇预计8月上旬获得上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2451695989","media":"E公司","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451695989?lang=zh_cn&edition=full","pubTime":"2024-07-16 17:39","pubTimestamp":1721122740,"startTime":"0","endTime":"0","summary":"e公司讯,近期,科兴制药(688136)白蛋白紫杉醇的产能及海外商业化进展引起市场关注。科兴制药在e互动平台回复中表示,公司白蛋白紫杉醇产线的规划产能为200万支,已于2024年4月通过欧盟GMP认证。合作方海昶生物提交的白蛋白紫杉醇的上市申请已于2024年5月获得EMA的积极回复,预计将于2024年8月上旬获得上市许可。白蛋白紫杉醇在欧盟的商业化预计将对公司的经营带来积极影响。白蛋白紫杉醇是欧洲医学肿瘤学会指南推荐治疗转移性胰腺癌和非小细胞肺癌的主流一线用药,治疗乳腺癌的二线用药。过去五年,欧洲癌症发病率呈上升趋势,白蛋白紫杉醇销量在欧洲市场逐步增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716173907af928e28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716173907af928e28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688136","BK0239"],"gpt_icon":0},{"id":"2450374155","title":"科兴制药07月12日主力资金流出24万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2450374155","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450374155?lang=zh_cn&edition=full","pubTime":"2024-07-12 15:17","pubTimestamp":1720768664,"startTime":"0","endTime":"0","summary":"07月12日, 科兴制药股价跌0.30%,报收16.38元,成交金额879万元,换手率0.27%,振幅2.31%,量比0.57。科兴制药今日主力资金净流出24万元,连续3日净流出,上一交易日主力净流出111万元,今日环比减少78.38%。近一年数据显示,该股主力连续3日净流出后,次日下跌概率为50.00%,平均跌幅为1.99%。该股近5个交易日上涨0.92%,主力资金累计净流入340万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流入203万元,其中净流入天数为7日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121522089f3a1280&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121522089f3a1280&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688136","BK0239"],"gpt_icon":0},{"id":"2449746564","title":"生物制品行业盘中跳水,科兴制药跌2.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449746564","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449746564?lang=zh_cn&edition=full","pubTime":"2024-07-08 14:03","pubTimestamp":1720418620,"startTime":"0","endTime":"0","summary":"07月08日,生物制品行业盘中跳水,截至14点03分,生物制品行业整体指数下跌3.03%,报5633.370点。从个股上来看,该行业的成分股中,科兴制药跌2.03%,博雅生物、派林生物、上海莱士跌幅居前。从资金上来看,截止发稿,生物制品行业主力净流入为-2.25亿,其中特宝生物受到资金热捧,主力净流入509.48万;拉长时间线来看,该板块近20日主力资金净流入-28.36亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081403409681a8c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407081403409681a8c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688136"],"gpt_icon":0},{"id":"2448913344","title":"科兴制药大跌5.06% 融资融券余额实现2连增","url":"https://stock-news.laohu8.com/highlight/detail?id=2448913344","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448913344?lang=zh_cn&edition=full","pubTime":"2024-07-04 13:26","pubTimestamp":1720070794,"startTime":"0","endTime":"0","summary":"07月04日,科兴制药股价大幅下跌,截至13点26分,科兴制药下跌5.06%,报15.40元/股,创近2月新低,成交1287万元,换手率0.41%。资金动向融资融券方面,科兴制药07月03日获得融资净买入1万元,当日该股融资余额为5876万元,当较前一日增加0.02%,实现2连增;该股融券余额为24万元,融券余量为1.59万股,比上日减少12.15%。最新财报显示,今年一季报,科兴制药实现营业收入3.61亿元,同比增长11.79%,净利润为1,240.34万元,同比增长241.49%,基本每股收益为0.06元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704132654af90809a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704132654af90809a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688136","BK0239"],"gpt_icon":0},{"id":"2446235561","title":"6月26日科兴制药涨5.05%,国新国证新锐灵活配置混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446235561","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446235561?lang=zh_cn&edition=full","pubTime":"2024-06-26 16:16","pubTimestamp":1719389792,"startTime":"0","endTime":"0","summary":"证券之星消息,6月26日科兴制药涨5.05%,收盘报17.27元,换手率0.49%,成交量9798.0手,成交额1657.13万元。重仓科兴制药的公募基金请见下表:该股最近90天内共有9家机构给出评级,买入评级6家,增持评级3家。根据2024基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为国新国证新锐灵活配置混合。该公募基金现任基金经理为张洪磊。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062600031299.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688136","BK0239"],"gpt_icon":0},{"id":"2446355980","title":"科兴制药涨5.05%,天风证券四周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2446355980","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446355980?lang=zh_cn&edition=full","pubTime":"2024-06-26 16:16","pubTimestamp":1719389788,"startTime":"0","endTime":"0","summary":"今日科兴制药涨5.05%,收盘报17.27元。2024年5月27日,天风证券研究员杨松,曹文清发布了对科兴制药的研报《稀缺新兴市场出海平台,2024Q1实现扭亏为盈》,该研报对科兴制药给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为79.7%。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为国元证券的朱仕平、马云涛。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062600031296.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601162","688136"],"gpt_icon":0},{"id":"2446334669","title":"科兴制药大幅上涨 获5家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2446334669","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446334669?lang=zh_cn&edition=full","pubTime":"2024-06-26 14:18","pubTimestamp":1719382686,"startTime":"0","endTime":"0","summary":"06月26日,科兴制药股价大幅上涨,截至14点18分,科兴制药上涨5.05%,报17.27元/股,成交1273万元,换手率0.38%。此外,数据统计显示,近半年内5家券商给予增持建议,9家券商给予买入建议。资金动向截止发稿,科兴制药获得主力净流出120万元。最新财报显示,今年一季报,科兴制药实现营业收入3.61亿元,同比增长11.79%,净利润为1,240.34万元,同比增长241.49%,基本每股收益为0.06元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626143408aef6a7f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626143408aef6a7f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688136"],"gpt_icon":0},{"id":"2445248040","title":"6月24日科兴制药跌5.99%,国新国证新锐灵活配置混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2445248040","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445248040?lang=zh_cn&edition=full","pubTime":"2024-06-24 16:22","pubTimestamp":1719217355,"startTime":"0","endTime":"0","summary":"证券之星消息,6月24日科兴制药跌5.99%,收盘报16.79元,换手率0.51%,成交量1.01万手,成交额1739.49万元。重仓科兴制药的公募基金请见下表:该股最近90天内共有9家机构给出评级,买入评级6家,增持评级3家。根据2024基金Q1季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为国新国证新锐灵活配置混合。该公募基金现任基金经理为张洪磊。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406241627039f5f0759&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406241627039f5f0759&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688136"],"gpt_icon":0},{"id":"2445017112","title":"科兴制药下跌5.1%,报16.95元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2445017112","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445017112?lang=zh_cn&edition=full","pubTime":"2024-06-24 13:49","pubTimestamp":1719208148,"startTime":"0","endTime":"0","summary":"6月24日,科兴制药盘中下跌5.1%,截至13:49,报16.95元/股,成交1257.38万元,换手率0.36%,总市值33.76亿元。截至3月31日,科兴制药股东户数1.01万,人均流通股1.98万股。2024年1月-3月,科兴制药实现营业收入3.61亿元,同比增长11.79%;归属净利润1240.34万元,同比增长241.49%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062413531995d136e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062413531995d136e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688136","BK0239"],"gpt_icon":0},{"id":"2445017117","title":"科兴制药大跌5.10% 近半年5家券商增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2445017117","media":"智选洞察","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445017117?lang=zh_cn&edition=full","pubTime":"2024-06-24 13:49","pubTimestamp":1719208144,"startTime":"0","endTime":"0","summary":"06月24日,科兴制药股价大幅下跌,截至13点49分,科兴制药下跌5.10%,报16.95元/股,成交1257万元,换手率0.36%,振幅5.04%。此外,数据统计显示,近半年内5家券商给予增持建议,9家券商给予买入建议。资金动向截止发稿,科兴制药获得主力净流出57万元,其中超大单流出2万元,大单流出54万元。最新财报显示,今年一季报,科兴制药实现营业收入3.61亿元,同比增长11.79%,净利润为1,240.34万元,同比增长241.49%,基本每股收益为0.06元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624135039aef63983&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624135039aef63983&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688136","BK0239"],"gpt_icon":0},{"id":"2445098487","title":"A股避雷针:科兴制药近日补缴超2000万税款及滞纳金,东方集团大股东部分股份被强制平仓打开手机微信扫一扫","url":"https://stock-news.laohu8.com/highlight/detail?id=2445098487","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445098487?lang=zh_cn&edition=full","pubTime":"2024-06-24 08:44","pubTimestamp":1719189884,"startTime":"0","endTime":"0","summary":"2连板美丽生态:内外部经营环境未发生重大变化2连板中信尼雅:公司近期未签订重大合同,一季度公司实现营收较上年同期减少55.42%,归属于上市公司股东的净利润减少90.59%科兴制药:公司于近日补缴税款及滞纳金2131.11万元东方集团:大股东东方润澜部分股份被强制平仓;因涉嫌信息披露违法违规,证监会决定对公司立案九菱科技:公司不生产金属软磁粉,相关传闻情况不属实云涌科技:公司暂未直接参与“车路云一","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406240848299f5da557&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406240848299f5da557&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0028","600811","BK0074","BK0196","BK0238","399300","688136","BK0004","159982","BK0239"],"gpt_icon":0},{"id":"2445055976","title":"科兴制药2024国际医药高端论坛成功举办并签署系列战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2445055976","media":"中国财富通","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445055976?lang=zh_cn&edition=full","pubTime":"2024-06-23 20:58","pubTimestamp":1719147521,"startTime":"0","endTime":"0","summary":"多家海外医药企业与主办方科兴制药签署了系列战略合作协议。科兴制药表示,为持续推动国际化战略,强力赋能全球高品质生物药的发展以及展现科兴最具价值的海外商业化平台实力,2024国际医药高端论坛全球化系列活动还将在多地甚至多国继续开展。当天会上,各合作方与科兴制药签署了一系列战略合作协议,不仅代表着双方持续合作的坚定信念,更象征着未来共同发展全球医药事业的美好愿景。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=cHM8gWo16VE%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","688136","09939","BK1515","159938","BK1161","BK0239"],"gpt_icon":0},{"id":"2445756835","title":"科兴制药(688136.SH):补缴税款及滞纳金合计2131.11万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445756835","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445756835?lang=zh_cn&edition=full","pubTime":"2024-06-21 19:48","pubTimestamp":1718970499,"startTime":"0","endTime":"0","summary":"智通财经APP讯,科兴制药(688136.SH)发布公告,国家税务总局济南市税务局第一稽查局对公司2021年1月1日至2022年12月31日涉税情况进行了检查,公司应补缴2021年企业所得税1548.77万元,需缴纳滞纳金582.34万元(截至实际缴纳日),合计需缴纳2131.11万元。截至公告披露日,公司已按要求将上述税款及滞纳金缴纳完毕,主管税务部门未对该事项给予处罚。公司补缴上述税款及滞纳金将计入2024年当期损益,预计将影响公司2024年度归属于上市公司股东的净利润约2131.11万元,最终以2024年度经审计的财务报表为准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1138866.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688136","BK0239"],"gpt_icon":0},{"id":"2445755340","title":"科兴制药:于近日补缴税款及滞纳金 合计2131.11万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445755340","media":"第一财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445755340?lang=zh_cn&edition=full","pubTime":"2024-06-21 19:13","pubTimestamp":1718968418,"startTime":"0","endTime":"0","summary":"科兴制药公告,国家税务总局济南市税务局第一稽查局对公司2021年1月1日至2022年12月31日涉税情况进行了检查,公司应补缴2021年企业所得税1,548.77万元,需缴纳滞纳金582.34万元(截至实际缴纳日),合计需缴纳2,131.11万元。截至本公告披露日,公司已按要求将上述税款及滞纳金缴纳完毕,主管税务部门未对该事项给予处罚。公司补缴上述税款及滞纳金将计入2024年当期损益,预计将影响公司2024年度归属于上市公司股东的净利润约2,131.11万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621191338af8ea08d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621191338af8ea08d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688136","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-12-14","address":"山东省济南市章丘区埠村街道创业路2666号","stockEarnings":[{"period":"1week","weight":-0.0256},{"period":"1month","weight":-0.0919},{"period":"3month","weight":-0.1021},{"period":"6month","weight":0.0201},{"period":"1year","weight":-0.1909},{"period":"ytd","weight":-0.2484}],"companyName":"科兴生物制药股份有限公司","boardCode":"AI0027","perCapita":"19767股","boardName":"医药制造业","registeredCapital":"19919万元","compareEarnings":[{"period":"1week","weight":-0.0124},{"period":"1month","weight":-0.0297},{"period":"3month","weight":-0.0726},{"period":"6month","weight":0.0392},{"period":"1year","weight":-0.1251},{"period":"ytd","weight":-0.0321}],"survey":" 科兴生物制药股份有限公司是一家主要从事重组蛋白药物和微生态制剂的研发、生产、销售一体化的创新型生物制药企业,专注于抗病毒、血液、肿瘤与免疫、退行性疾病等治疗领域的药物研发,并围绕上述治疗领域拥有一定中药及化学药技术沉淀。目前公司主要产品包括重组蛋白药物“重组人促红素”、“重组人干扰素α1b”、“重组人粒细胞刺激因子”,微生态制剂药物“酪酸梭菌二联活菌”。公司是中国重组蛋白药物的领军企业,建立了完善的生物药研发创新体系,涵盖了原核细胞技术、真核细胞技术、微生态活菌技术三大生物技术基础体系。","serverTime":1722367256282,"listedPrice":22.33,"stockholders":"10077人(较上一季度减少11.92%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科兴制药(688136)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科兴制药(688136)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科兴制药,688136,科兴制药股票,科兴制药股票老虎,科兴制药股票老虎国际,科兴制药行情,科兴制药股票行情,科兴制药股价,科兴制药股市,科兴制药股票价格,科兴制药股票交易,科兴制药股票购买,科兴制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科兴制药(688136)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科兴制药(688136)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}